Monday, November 11, 2024 10:17:36 AM
Current Outset Medical shareholders who have continuously held Outset Medical shares since prior to August 1, 2022, can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award at no cost to them.
If you would like to learn more about this matter at no cost to you, you are encouraged to visit https://grabarlaw.com/the-latest/outsetmedical-shareholder-investigation/, contact Joshua H. Grabar at jgrabar @FH-6085.
If you would like to learn more about this matter at no cost to you, you are encouraged to visit https://grabarlaw.com/the-latest/outsetmedical-shareholder-investigation/, contact Joshua H. Grabar at jgrabar @FH-6085.
Recent OM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 09:21:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 09:19:32 PM
- Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/08/2026 08:05:00 PM
- Outset Medical Names Derick Elliott as Executive Vice President of Commercial • GlobeNewswire Inc. • 04/06/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:56:10 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/18/2026 02:13:36 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:14:59 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2026 09:21:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/13/2026 09:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:15:26 PM
- Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/11/2026 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 02:10:27 PM
- Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned • GlobeNewswire Inc. • 01/27/2026 02:00:00 PM
- Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 • GlobeNewswire Inc. • 01/26/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2026 12:07:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2026 12:05:50 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/21/2026 11:26:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/21/2026 11:25:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/21/2026 01:13:55 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/21/2026 01:11:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:25:08 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:15:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:31:06 PM
- Outset Medical Reports Unaudited Fourth Quarter and 2025 Results • GlobeNewswire Inc. • 01/12/2026 01:30:00 PM
